Chromatin structure, epigenetic mechanisms and long-range interactions in the human insulin locus

Diabetes, Obesity and Metabolism

Volumn 14, Issue SUPPL.3, 2012, Pages 1-11

  Xu, Z ^a   Lefevre, G M ^a   Felsenfeld, G ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Chromatin conformation capture (3C); Histones; Synaptotagmin 8 (SYT8)

Indexed keywords

GLUCOSE; INSULIN; UNTRANSLATED RNA;

CHROMATIN STRUCTURE; DOWN REGULATION; EPIGENETICS; GENE; GENE EXPRESSION; GENE INTERACTION; GENE LOCUS; GENOME IMPRINTING; GENOMICS; H19 GENE; HUMAN; IGF2 GENE; INS GENE; INSULIN RELEASE; NONHUMAN; PANCREAS ISLET; PROMOTER REGION; REVIEW; SYT8 GENE;

EID: 84865605602     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2012.01645.x     Document Type: Review

References (64)

1. Voss TC, Schiltz RL, Sung MH et al. Dynamic exchange at regulatory elements during chromatin remodeling underlies assisted loading mechanism. Cell 2011; 146: 544-554.
2. Heintzman ND, Stuart RK, Hon G et al. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet 2007; 39: 311-318.
3. Talbot D, Collis P, Antoniou M et al. A dominant control region from the human beta-globin locus conferring integration site-independent gene expression. Nature 1989; 338: 352-355.
4. Forrester WC, Takegawa S, Papayannopoulou T, Stamatoyannopoulos G, Groudine M. Evidence for a locus activation region: the formation of developmentally stable hypersensitive sites in globin-expressing hybrids. Nucleic Acids Res 1987; 15: 10159-10177.
5. Dillon N, Trimborn T, Strouboulis J, Fraser P, Grosveld F. The effect of distance on long-range chromatin interactions. Mol Cell 1997; 1: 131-139.
6. Felsenfeld G, Burgess-Beusse B, Farrell C et al. Chromatin boundaries and chromatin domains. Cold Spring Harb Symp Quant Biol 2004; 69: 245-250.
7. Chung JH, Whiteley M, Felsenfeld G. A 5' element of the chicken beta-globin domain serves as an insulator in human erythroid cells and protects against position effect in Drosophila. Cell 1993; 74: 505-514.
8. Bell AC, West AG, Felsenfeld G. The protein CTCF is required for the enhancer blocking activity of vertebrate insulators. Cell 1999; 98: 387-396.
9. Phillips JE, Corces VG. Ctcf: master weaver of the genome. Cell 2009; 137: 1194-1211.
10. Yusufzai TM, Tagami H, Nakatani Y, Felsenfeld G. CTCF tethers an insulator to subnuclear sites, suggesting shared insulator mechanisms across species. Mol Cell 2004; 13: 291-298.
11. Bell AC, Felsenfeld G. Methylation of a CTCF-dependent boundary controls imprinted expression of the igf2 gene. Nature 2000; 405: 482-485.
12. Kanduri C, Pant V, Loukinov D et al. Functional association of CTCF with the insulator upstream of the h19 gene is parent of origin-specific and methylation-sensitive. Curr Biol 2000; 10: 853-856.
13. Kurukuti S, Tiwari VK, Tavoosidana G et al. CTCF binding at the h19 imprinting control region mediates maternally inherited higher-order chromatin conformation to restrict enhancer access to igf2. Proc Natl Acad Sci USA 2006; 103: 10684-10689.
14. Monk D, Sanches R, Arnaud P et al. Imprinting of IGF2 p0 transcript and novel alternatively spliced INS-IGF2 isoforms show differences between mouse and human. Hum Mol Genet 2006; 15: 1259-1269.
15. Mutskov V, Felsenfeld G. The human insulin gene is part of a large open chromatin domain specific for human islets. Proc Natl Acad Sci USA 2009; 106: 17419-17424.
16. Stitzel ML, Sethupathy P, Pearson DS et al. Global epigenomic analysis of primary human pancreatic islets provides insights into type 2 diabetes susceptibility loci. Cell Metab 2010; 12: 443-455.
17. Wapinski O, Chang HY. Long noncoding RNAs and human disease. Trends Cell Biol 2011; 21: 354-361.
18. Ferguson LA, Docherty HM, MacKenzie AE, Docherty K. An engineered zinc finger protein reveals a role for the insulin VNTR in the regulation of the insulin and adjacent IGF2 genes. FEBS Lett 2009; 583: 3181-3186.
19. Ohneda K, Ee H, German M. Regulation of insulin gene transcription. Semin Cell Dev Biol 2000; 11: 227-233.
20. Dekker J, Rippe K, Dekker M, Kleckner N. Capturing chromosome conformation. Science 2002; 295: 1306-1311.
21. Simonis M, Klous P, Splinter E et al. Nuclear organization of active and inactive chromatin domains uncovered by chromosome conformation capture-on-chip (4c). Nat Genet 2006; 38: 1348-1354.
22. Zhao Z, Tavoosidana G, Sjolinder M et al. Circular chromosome conformation capture (4c) uncovers extensive networks of epigenetically regulated intra- and interchromosomal interactions. Nat Genet 2006; 38: 1341-1347.
23. Xu Z, Wei G, Chepelev I, Zhao K, Felsenfeld G. Mapping of ins promoter interactions reveals its role in long-range regulation of syt8 transcription. Nat Struct Mol Biol 2011; 18: 372-378.
24. Dostie J, Richmond TA, Arnaout RA et al. Chromosome conformation capture carbon copy (5c): a massively parallel solution for mapping interactions between genomic elements. Genome Res 2006; 16: 1299-1309.
25. Lieberman-Aiden E, van Berkum NL, Williams L et al. Comprehensive mapping of long-range interactions reveals folding principles of the human genome. Science 2009; 326: 289-293.
26. Horike S, Cai S, Miyano M, Cheng JF, Kohwi-Shigematsu T. Loss of silent-chromatin looping and impaired imprinting of dlx5 in rett syndrome. Nat Genet 2005; 37: 31-40.
27. Fullwood MJ, Liu MH, Pan YF et al. An oestrogen-receptor-alpha-bound human chromatin interactome. Nature 2009; 462: 58-64.
28. Marban SL, DeLoia JA, Gearhart JD. Hyperinsulinemia in transgenic mice carrying multiple copies of the human insulin gene. Dev Genet 1989; 10: 356-364.
29. Karaca M, Durel B, Languille L et al. Transgenic expression of human ins gene in ins1/ins2 double knockout mice leads to insulin underproduction and diabetes in some male mice. Front Biosci 2007; 12: 1586-1593.
30. Leighton PA, Saam JR, Ingram RS, Stewart CL, Tilghman SM. An enhancer deletion affects both h19 and IGF2 expression. Genes Dev 1995; 9: 2079-2089.
31. Leighton PA, Ingram RS, Eggenschwiler J, Efstratiadis A, Tilghman SM. Disruption of imprinting caused by deletion of the h19 gene region in mice. Nature 1995; 375: 34-39.
32. Bennett ST, Wilson AJ, Esposito L et al. Insulin VNTR allele-specific effect in type 1 diabetes depends on identity of untransmitted paternal allele. The IMDIAB Group. Nat Genet 1997; 17: 350-352.
33. Duvillie B, Bucchini D, Tang T, Jami J, Paldi A. Imprinting at the mouse ins2 locus: evidence for cis- and trans-allelic interactions. Genomics 1998; 47: 52-57.
34. Rassoulzadegan M, Grandjean V, Gounon P et al. RNA-mediated non-mendelian inheritance of an epigenetic change in the mouse. Nature 2006; 441: 469-474.
35. Onyango P, Miller W, Lehoczky J et al. Sequence and comparative analysis of the mouse 1-megabase region orthologous to the human 11p15 imprinted domain. Genome Res 2000; 10: 1697-1710.
36. Kassem SA, Ariel I, Thornton PS et al. P57(kip2) expression in normal islet cells and in hyperinsulinism of infancy. Diabetes 2001; 50: 2763-2769.
37. Sempoux C, Guiot Y, Dahan K et al. The focal form of persistent hyperinsulinemic hypoglycemia of infancy: morphological and molecular studies show structural and functional differences with insulinoma. Diabetes 2003; 52: 784-794.
38. Gustavsson N, Lao Y, Maximov A et al. Impaired insulin secretion and glucose intolerance in synaptotagmin-7 null mutant mice. Proc Natl Acad Sci USA 2008; 105: 3992-3997.
39. 2+-dependent insulin secretion in islets. FEBS Lett 2005; 579: 5241-5246.
40. Babu DA, Chakrabarti SK, Garmey JC, Mirmira RG. Pdx1 and beta2/neurod1 participate in a transcriptional complex that mediates short-range DNA looping at the insulin gene. J Biol Chem 2008; 283: 8164-8172.
41. Emens LA, Landers DW, Moss LG. Hepatocyte nuclear factor 1 alpha is expressed in a hamster insulinoma line and transactivates the rat insulin i gene. Proc Natl Acad Sci USA 1992; 89: 7300-7304.
42. Kitanaka S, Sato U, Igarashi T. Regulation of human insulin, IGF-i, and multidrug resistance protein 2 promoter activity by hepatocyte nuclear factor (hnf)-1beta and hnf-1alpha and the abnormality of HNF-1beta mutants. J Endocrinol 2007; 192: 141-147.
43. Bartoov-Shifman R, Hertz R, Wang H et al. Activation of the insulin gene promoter through a direct effect of hepatocyte nuclear factor 4 alpha. J Biol Chem 2002; 277: 25914-25919.
44. O'Rahilly S. Human genetics illuminates the paths to metabolic disease. Nature 2009; 462: 307-314.
45. Murphy R, Baptista J, Holly J et al. Severe intrauterine growth retardation and atypical diabetes associated with a translocation breakpoint disrupting regulation of the insulin-like growth factor 2 gene. J Clin Endocrinol Metab 2008; 93: 4373-4380.
46. Vu TH, Nguyen AH, Hoffman AR. Loss of IGF2 imprinting is associated with abrogation of long-range intrachromosomal interactions in human cancer cells. Hum Mol Genet 2010; 19: 901-919.
47. Guttman M, Rinn JL. Modular regulatory principles of large non-coding RNAs. Nature 2010; 482: 339-346.
48. Wang KC, Chang HY. Molecular mechanisms of long noncoding RNAs. Mol Cell 2011; 43: 904-914.
49. Orom UA, Shiekhattar R. Noncoding RNAs and enhancers: complications of a long-distance relationship. Trends Genet 2011; 27: 433-439.
50. Kanduri C. Kcnq1ot1: a chromatin regulatory RNA. Semin Cell Dev Biol 2011; 22: 343-350.
51. Mohammad F, Mondal T, Guseva N, Pandey GK, Kanduri C. Kcnq1ot1 noncoding RNA mediates transcriptional gene silencing by interacting with Dnmt1. Development 2010; 137: 2493-2499.
52. Pandey RR, Mondal T, Mohammad F et al. Kcnq1ot1 antisense noncoding RNA mediates lineage-specific transcriptional silencing through chromatin-level regulation. Mol Cell 2008; 32: 232-246.
53. Jones MJ, Bogutz AB, Lefebvre L. An extended domain of kcnq1ot1 silencing revealed by an imprinted fluorescent reporter. Mol Cell Biol 2011; 31: 2827-2837.
54. Temple IK, Shield JP. 6q24 transient neonatal diabetes. Rev Endocr Metab Disord 2010; 11: 199-204.
55. Mackay DJ, Boonen SE, Clayton-Smith J et al. A maternal hypomethylation syndrome presenting as transient neonatal diabetes mellitus. Hum Genet 2006; 120: 262-269.
56. Arima T, Kamikihara T, Hayashida T et al. Zac, lit1 (kcnq1ot1) and p57kip2 (cdkn1c) are in an imprinted gene network that may play a role in Beckwith-Wiedemann syndrome. Nucleic Acids Res 2005; 33: 2650-2660.
57. Mackay DJ, Hahnemann JM, Boonen SE et al. Epimutation of the TNDM locus and the beckwith-wiedemann syndrome centromeric locus in individuals with transient neonatal diabetes mellitus. Hum Genet 2006; 119: 179-184.
58. Scott LJ, Mohlke KL, Bonnycastle LL et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 2007; 316: 1341-1345.
59. Visel A, Zhu Y, May D et al. Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice. Nature 2010; 464: 409-412.
60. Tomikawa J, Shimokawa H, Uesaka M et al. Single-stranded noncoding rnas mediate local epigenetic alterations at gene promoters in rat cell lines. J Biol Chem 2011; 286: 34788-34799.
61. Li G, Ruan X, Auerbach RK et al. Extensive promoter-centered chromatin interactions provide a topological basis for transcription regulation. Cell 2012; 148: 84-98.
62. Kong A, Steinthorsdottir V, Masson G et al. Parental origin of sequence variants associated with complex diseases. Nature 2009; 462: 868-874.
63. Yasuda K, Miyake K, Horikawa Y et al. Variants in kcnq1 are associated with susceptibility to type 2 diabetes mellitus. Nat Genet 2008; 40: 1092-1097.
64. Pugliese A, Miceli D. The insulin gene in diabetes. Diabetes Metab Res Rev 2002; 18: 13-25.